Schedule 13G ownership disclosure
Galera Therapeutics, Inc.
Security class unavailable · CUSIP: 86338D108
Event date: 2023-10-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,280,000
- Percent of class
- 12.0200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-117077
- Form type
- SC 13G
- Filer
- Altamont Pharmaceutical Holdings, LLC
- CIK
- CIK 1745878
- Filed
- Nov 13, 2023
- Reporting period
- Oct 31, 2023
- Description
- Schedule 13G beneficial ownership